Moderna posts surprise quarterly profit even as Covid vaccines sales plummet

Moderna’s stock pops after surprise quarterly profit, even as COVID sales continue to slide

Moderna on Thursday reported a surprise fourth-quarter profit even as its COVID product sales continue to plunge.

Moderna posts surprise quarterly profit even as Covid vaccines sales plummet

Moderna reiterated its full-year 2024 sales guidance of roughly $4 billion.

Moderna Makes Surprise Profits On Covid Vaccines

(CTN News) – Despite slumping sales of the Covid vaccine, the company’s only marketable product, Moderna posted a surprise quarterly profit on Thursday. With the world emerging from pandemics and utilising fewer protective shots and treatments, the biotech company and other Covid vaccine makers have had a rocky year. According to LSEG, formerly known as […]